Carisma TherapeuticsCARM
13F holders, Q3 2025 (September 30)33holders −3
3new positions
6sold out
1famous investor
$0.27avg. 13F price*
At the end of Q3 2025, 33 institutions reported holding Carisma Therapeutics Inc. (CARM) in their 13F filings, down 3 from Q2 2025. 3 opened new positions and 6 sold out. The largest holders were Merck & Co., Inc. ($404K), Vanguard Group Inc. ($96K) and BlackRock, Inc. ($92K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Carisma Therapeutics Inc.
- CUSIP
- 14216R101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $9K |
| Exits | 6 | $345K |
All 13F filers, Q2 2025 → Q3 2025: 37,607 shares bought and 944,068 shares sold, net −906,461 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Merck & Co., Inc. | 0.18% | No change | 1,473,240 | $404K |
| Vanguard Group Inc. | 0.00% | No change | 350,324 | $96K |
| BlackRock, Inc. | 0.00% | No change | 336,789 | $92K |
| Renaissance Technologies | 0.00% | Reduce -10.8% | 293,686 | $80K |
| Geode Capital Management, LLC | 0.00% | No change | 250,495 | $69K |
| State Street Corp. | 0.00% | No change | 85,106 | $23K |
| Northern Trust Corp. | 0.00% | No change | 55,039 | $15K |
| GTS Securities LLC | 0.00% | No change | 50,118 | $14K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 30,988 | $8K |
| Empowered Funds, LLC | 0.00% | No change | 30,988 | $8K |
| Blodgett Wealth Advisors, LLC | 0.00% | No change | 24,001 | $7K |
| Virtu Financial LLC | 0.00% | New | 22,854 | $6K |
| Goldman Sachs Group Inc. | 0.00% | Add +26.0% | 16,410 | $4K |
| Dynamic Financial Group | 0.00% | No change | 15,350 | $4K |
| Two Sigma Securities, LLC | 0.00% | Reduce -28.5% | 12,828 | $4K |
| Citigroup Inc. | 0.00% | New | 11,274 | $3K |
| UBS Group AG | 0.00% | Reduce -68.2% | 7,032 | $2K |
| Morgan Stanley | 0.00% | No change | 3,185 | $873 |
| Group One Trading LLC | 0.00% | No change | 2,230 | $611 |
| Bank of America Corp. | 0.00% | Add +4.7% | 1,398 | $383 |
| JPMorgan Chase & Co. | 0.00% | No change | 921 | $252 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 535 | $131 |
| BNP Paribas Financial Markets | 0.00% | No change | 347 | $95 |
| IFP Advisors, Inc | 0.00% | No change | 206 | $56 |
| ORG Partners LLC | 0.00% | No change | 200 | $54 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 150 | $41 |
| Osaic Holdings, Inc. | 0.00% | No change | 142 | $29 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -18.9% | 107 | $29 |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 100 | $27 |
| National Bank of Canada | 0.00% | No change | 50 | $13 |
| Harbour Investments, Inc. | 0.00% | No change | 37 | $10 |
| Jones Financial Companies LLLP | 0.00% | No change | 16 | $5 |
| Royal Bank of Canada | 0.00% | New | 32 | $0 |
"% of holder's portfolio" is CARM's weight in each manager's 13F, not the share of Carisma Therapeutics Inc. the manager owns.